59
Development and Progression of AMD
References:
1. Klein R, Klein BE, Linton KL. Prevalence of age-related macu-
lopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99
(6): 933-943.
2. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence
and progression of age-related maculopathy: the Beaver Dam Eye
Study. Ophthalmology 1997; 104 (1): 7-21.
3. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini
MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP,
Loewenstein JI, Dawber TR. The Framingham Eye Study mono-
graph: An ophthalmological and epidemiological study of cata-
ract, glaucoma, diabetic retinopathy, macular degeneration, and
visual acuity in a general population of 2631 adults, 1973-1975.
Surv Ophthalmol 1980; 24 (Suppl): 335-610.
4. Green WR, Enger C. Age-related macular degeneration his-
topathologic studies. The 1992 Lorenz E. Zimmerman Lecture.
Ophthalmology 1993; 100 (10): 1519-1535.
5. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clin-
icopathologic correlation of drusen and retinal pigment epithelial
abnormalities in age-related macular degeneration. Retina 1994;
14 (2): 130-142.
6. Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes
in Bruch‘s membrane. A histochemical and morphologic study.
Ophthalmology 1990; 97 (2): 171-178.
7. Risk factors for choroidal neovascularization in the second eye of
patients with juxtafoveal or subfoveal choroidal neovascularization
secondary to age-related macular degeneration. Macular Photo-
coagulation Study Group. Arch Ophthalmol 1997; 115 (6): 741-
747.
8. Solomon SD, Jefferys JL, Hawkins BS, Bressler NM. Incident
choroidal neovascularization in fellow eyes of patients with unilat-
eral subfoveal choroidal neovascularization secondary to age-relat-
ed macular degeneration: SST report No. 20 from the Submacular
Surgery Trials Research Group. Arch Ophthalmol 2007; 125 (10):
1323-1330.
9. Five-year follow-up of fellow eyes of patients with age-related
macular degeneration and unilateral extrafoveal choroidal neovas-
cularization. Macular Photocoagulation Study Group. Arch Oph-
thalmol 1993; 111 (9): 1189-1199.
10. Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Bug-
gage R, Fahrbach K, Probst C, Sledge I. The natural history and
prognosis of neovascular age-related macular degeneration: a sys-
tematic review of the literature and meta-analysis. Ophthalmology
2008; 115 (1): 116-126.
11. Ross RJ, Verma V, Rosenberg KI, Chan CC, Tuo J. Genetic mark-
ers and biomarkers for age-related macular degeneration. Expert
Rev Ophthalmol 2007; 2 (3): 443-457.
12. Choroidal neovascularization in the Choroidal Neovascularization
Prevention Trial. The Choroidal Neovascularization Prevention
Trial Research Group. Ophthalmology 1998; 105 (8): 1364-1372.
13. Chang B, Yannuzzi LA, Ladas ID, Guyer DR, Slakter JS, Sorenson
JA. Choroidal neovascularization in second eyes of patients with
unilateral exudative age-related macular degeneration. Ophthal-
mology 1995; 102 (9): 1380-1386.
14. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Hen-
ning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB,
Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H poly-
morphism in age-related macular degeneration. Science 2005; 308
(5720): 385-389.
15. Edwards AO, Ritter R, III, Abel KJ, Manning A, Panhuysen C,
Farrer LA. Complement factor H polymorphism and age-related
macular degeneration. Science 2005; 308 (5720): 421-424.
16. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ,
Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs
KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I et
al. A common haplotype in the complement regulatory gene fac-
tor H (HF1/CFH) predisposes individuals to age-related macular
degeneration. Proc Natl Acad Sci U S A 2005; 102 (20): 7227-
7232.
17. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K,
Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman
GS, Dean M, Allikmets R. Variation in factor B (BF) and com-
plement component 2 (C2) genes is associated with age-related
macular degeneration. Nat Genet 2006; 38 (4): 458-462.
18. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins
P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-
Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Comple-
ment factor H variant increases the risk of age-related macular
degeneration. Science 2005; 308 (5720): 419-421.
19. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, An-
derson DH, Mullins RF. An integrated hypothesis that considers
drusen as biomarkers of immune-mediated processes at the RPE-
Bruch’s membrane interface in aging and age-related macular de-
generation. Prog Retin Eye Res 2001; 20 (6): 705-732.
20. Schaumberg DA, Christen WG, Kozlowski P, Miller DT, Ridker
PM, Zee RY. A prospective assessment of the Y402H variant in
complement factor H, genetic variants in C-reactive protein, and
risk of age-related macular degeneration. Invest Ophthalmol Vis
Sci 2006; 47 (6): 2336-2340.
21. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Associa-
tion between C-reactive protein and age-related macular degen-
eration. JAMA 2004; 291 (6): 704-710.
22. Seddon JM, George S, Rosner B, Rifai N. Progression of age-re-
lated macular degeneration: prospective assessment of C-reactive
protein, interleukin 6, and other cardiovascular biomarkers. Arch
Ophthalmol 2005; 123 (6): 774-782.
23. Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE,
Chan W, Knox A, Cartmill B, Chakravarthy U. Cardiovascular
disease and hypertension are strong risk factors for choroidal neo-
vascularization. Ophthalmology 2008; 115 (6): 1046-1052.e2.
24. Klein R, Klein BE, Knudtson MD, Wong TY, Shankar A, Tsai
MY. Systemic markers of inflammation, endothelial dysfunction,
and age-related maculopathy. Am J Ophthalmol 2005; 140 (1):
35-44.
25. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-relat-
